Rhumbline Advisers Has $97,000 Stock Position in Kyverna Therapeutics, Inc. (NASDAQ:KYTX)
Rhumbline Advisers raised its holdings in Kyverna Therapeutics, Inc. (NASDAQ:KYTX – Free Report) by 31.1% in the 4th quarter, according to the company in its most recent filing with the SEC. The firm owned 25,920 shares of the company’s stock after acquiring an additional 6,153 shares during the quarter. Rhumbline Advisers’ holdings in Kyverna Therapeutics […]
